Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin prophylaxis for travellers' diarrhoea to South and Southeast Asia
2007-003986-42Phase 3Completed
- Sponsor
- University Hospital Tübingen
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diarrhea, gastroenteritis and irritable bowel syndrome (IBS) comparing rifaximin prophylaxis with placebo control (2 arms). Primary endpoint: Prevention of travellers' diarrhoea. Started Oct 2007; status: completed.
02
Drugs
rifaximin
03
Conditions
diarrheagastroenteritisirritable bowel syndrome (IBS)
Beyond the preview
Go deeper on 2007-003986-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003986-42.